CS
OCAT

Credit Suisse’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Credit Suisse’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,231
Closed -$51K – 4492
2015
Q3 		$51K Sell
12,231
-12,259
-50% -$53.5K ﹤0.01% 4174
2015
Q2 		$130K Buy
+24,490
New +$157K ﹤0.01% 4340

Other funds holding OCAT

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse's OCAT Position: Q4 2015 in Review

Credit Suisse sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q4 2015, closing a stake of 12,231 shares — an estimated $51K sold.

Credit Suisse first reported a position in OCAT in Q2 2015 and held it in 2 quarters. The position peaked at $130K in Q2 2015. 77 funds tracked by Wall St. Rank hold OCAT as of Q4 2015.

  • Credit Suisse reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q4 2015 after selling out during the quarter.
  • Credit Suisse sold 12,231 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q4 2015, an estimated $51K.
  • Credit Suisse first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 2 quarters.
  • Credit Suisse's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $130K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q4 2015.

Based on Credit Suisse's 13F filing for Q4 2015, filed 16 Feb 2016.